Search

everythinglearnresearchcommunity

for

Search:↓

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Hair loss can lead to significant stigma and lower quality of life, especially for women and those with certain types of alopecia.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Adipose-derived stem cells show promise in treating skin conditions like vitiligo, alopecia, and nonhealing wounds.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The study found that urine metabolites M1b or M4 are the best indicators of ATD use in horses, with detection possible up to 77 hours in urine and 28 hours in blood.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Keratinocytes help keep hair follicle cells and skin cells separate in 3D cultures, which is important for hair growth research.

Propranolol is effective and safe for treating infantile hemangioma, but more research is needed for dosing and monitoring guidelines.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Spheroid culture in agarose dishes improves survival and nerve cell growth in thawed human fat-derived stem cells.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Niosomes are a promising and effective way to deliver drugs through the skin.

New treatments for lupus show promise, but more research is needed, especially for children.

Baricitinib shows promise as a new treatment for certain skin conditions like alopecia areata.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Changing the diet of mice lacking the enzyme CBS can affect symptoms related to the genetic condition.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.